Latanoprost/timolol

Drug Profile

Latanoprost/timolol

Alternative Names: Timolol/latanoprost; Xalacom; Xalatan/timolol; Xalcom

Latest Information Update: 09 Feb 2012

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Pfizer
  • Class Amino alcohols; Antiglaucomas; Antihypertensives; Eye disorder therapies; Morpholines; Propanolamines; Prostaglandins; Small molecules; Thiadiazoles
  • Mechanism of Action Beta-adrenergic receptor antagonists; Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Glaucoma; Ocular hypertension

Most Recent Events

  • 08 Feb 2012 Generic equivalent available in United Kingdom
  • 25 Jan 2012 Generic equivalent available in Denmark, Finland & Ireland
  • 28 Jun 2003 Launched for Glaucoma in Canada (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top